Results 141 to 150 of about 11,492 (193)

[Exploration of the mechanisms of portal hypertension driven by metabolic disorders in non-cirrhotic stages of metabolic-associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhao YQ, Wang Y, Liu JJ, You H, Zhao JJ.
europepmc   +1 more source

Machine Learning Identifies SCO2 as a Metabolic Reprogramming Gene Promoting Lipid Accumulation in MAFLD. [PDF]

Biofactors
Li A, Xu R, Zhang L, Xu X, Dai L, Zhang Z.   +5 more
europepmc   +1 more source

Wendan decoction modulates Parasutterella to influence fatty acid metabolism in MAFLD via the FXR/PPARα/CYP4A12A axis. [PDF]

Chin Med
Zhang Y, Wang J, Zhu W, Zhang Y, Ma T, Fang H, Du J, Chen Z, Li W, Zhang X, Wu L, Chen X, Hua H.   +12 more
europepmc   +1 more source

MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study” [PDF]

Clinical and Molecular Hepatology
Ying Wang, Shengfeng Wang, Xiude Fan, Jiajun Zhao, Yongfeng Song   +4 more
doaj   +1 more source

Association between occupational noise exposure and metabolic dysfunction-associated fatty liver disease: the mediating role of body mass index in automotive manufacturing workers. [PDF]

Front Public Health
Chen Z, Yu J, Ou S, Ruan Y, Rong X, Zhang Y, Huang H, Cui J, Wang Z.   +8 more
europepmc   +1 more source

Transcriptomic analysis identifies FABP5 as a candidate regulator of lipid accumulation in metabolic dysfunction-associated fatty liver disease. [PDF]

Front Endocrinol (Lausanne)
Lv K, Zhong S, Liu X, Zhou J, Lu D, Luo X, Tu L, Zhou B, Han S, Zhang B, Li X, Ye JD, Yang Z.   +12 more
europepmc   +1 more source

Multi-Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease. [PDF]

Pharmacol Res Perspect
Wei Y, Wei D, Lu J, Wei L, Lin W, Wei J, Ma X.   +6 more
europepmc   +1 more source

Association of Sleep Characteristics With Suspected Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Risk Among Adults Attending a Community Health Center. [PDF]

Cureus
Prabhakar T, Jois GS, Singh SV, Saini B, Mohan A.   +4 more
europepmc   +1 more source

Comparative discriminative ability of CVAI and traditional insulin resistance indices for MAFLD in Chinese adults with type 2 diabetes. [PDF]

Front Endocrinol (Lausanne)
Yang J, Xie F, Zhu X, Zhou H.
europepmc   +1 more source

Metabolic dysfunction-associated fatty liver disease exacerbates hematoma expansion in intracerebral hemorrhage: an explainable machine learning approach. [PDF]

Front Endocrinol (Lausanne)
Yang Z, He J, Song Y, Meng Q.
europepmc   +1 more source